Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R L Marier
N-Formimidoyl Thienamycin (MK0787): In Vitro Activity Against Anaerobic Bacteria.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
In Vitro Activity of N-Formimidoyl Thienamycin (MK0787), a Crystalline Derivative of Thienamycin.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of MK0787 (N-Formimidoyl Thienamycin) and Other Beta-Lactam Compounds Against Bacteroides Spp.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Activity of N-Formimidoyl Thienamycin and Cephalosporins Against Isolates From Nosocomially Acquired Bacteremia.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of N-Formimidoyl Thienamycin in Comparison With Cefotaxime, Moxalactam, and Ceftazidime.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative in Vitro Activities of N-Formimidoyl Thienamycin and Moxalactam Against Nonfermentative Aerobic Gram-Negative Rods
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of Cefbuperazone Against Anaerobic Bacteria.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A Comparison of the Antibacterial Activities of N-Formimidoyl Thienamycin (MK0787) With Those of Other Recently Developed Beta-Lactam Derivatives.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of FK037, a New Parenteral Cephalosporin, Against Anaerobic Bacteria.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative in Vitro Activity of Cefbuperazone Against Anaerobic Bacteria Isolated From Community Hospitals.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology